Stella Diagnostics Inc.
SLDX · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $16,064 | $17,269 | $16,867 | $20,482 |
| - Cash | $12 | $5 | $7 | $4 |
| + Debt | $6,961 | $6,643 | $6,657 | $6,584 |
| Enterprise Value | $23,013 | $23,907 | $23,517 | $27,061 |
| Revenue | $201 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$125 | $0 | $0 | $0 |
| % Margin | -62.2% | – | – | – |
| EBITDA | -$616 | -$230 | -$237 | -$385 |
| % Margin | -306.2% | – | – | – |
| Net Income | -$647 | -$230 | -$280 | -$330 |
| % Margin | -321.5% | – | – | – |
| EPS Diluted | -0.002 | -0.001 | -0.001 | -0.001 |
| % Growth | -166.7% | 14.3% | 12.5% | – |
| Operating Cash Flow | -$316 | $638 | -$53 | -$42 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$316 | $638 | -$53 | -$42 |